The Canadian Hypertension Education Program (CHEP) recommendations: launching a new series
- A nationwide population screening program for diabetes in Brazil. Nucci, Luciana B.; Toscano, Cristiana M.; Maia, Ana Lourdes M.; Fonseca, Cláudio D.; Britto, Maria Moema B.; Duncan, Bruce B.; Schmidt, Maria Inês // Revista Panamericana de Salud Publica;Nov2004, Vol. 16 Issue 5, p320
Objectives. In 2001, persons throughout Brazil who were 40 years old or older were invited to participate in community screening for diabetes as part of the Brazilian Ministry of Health's Plan for the Reorganization of Care for Arterial Hypertension and Diabetes Mellitus. This report describes...
- Rapid Reduction of Severe Asymptomatic Hypertension: A Prospective, Controlled Trial. // JAMA: Journal of the American Medical Association;2/23/90, Vol. 263 Issue 8, p1078
Discusses the abstract of a research study concerning the rapid reduction of severe asymptomatic hypertension, conducted by Kathleen R. Zeller and colleagues.
- Training for skeletal muscle capillarization: a Janus-faced role of exercise intensity? Gliemann, Lasse // European Journal of Applied Physiology;Aug2016, Vol. 116 Issue 8, p1443
An introduction is presented which discusses various reports published within the issue on topics including exercise pulmonary hypertension, blood circulation disorders and cardiovascular diseases.
- making sense of the new blood pressure guidelines. Martin, Adam // Health (Time Inc. Health);Sep2003, Vol. 17 Issue 7, p65
Looks at the changes made to the federal guidelines on prehypertensive people in the U.S. People who are considered prehypertensive; Reason for the changes in the guidelines; Advice for prehypertensive people.
- NICE signals significant changes in BP guidance. // Pulse;11/5/2005, Vol. 65 Issue 43, p4
Reports on the study which found that the ASCOT trial is likely to have a significant impact on new NICE and British Hypertension Society guidelines for hypertension in Great Britain. Confirmation of the need for a wider evaluation of hypertension guidance; Improvement of the first-line therapy;...
- Treatment and prevention of hypertension: Where have we been and where are we going? Luft, Friedrich C. // Kidney International Supplement;Aug1995, Issue 50, pS-14
Explores the modality of treatment and prevention of hypertension. Identification of genes associated with blood pressure regulation and the development of hypertension; Application of diuretics and beta blockers; Influence of environmental factors on blood pressure.
- CIRCULATORY DISORDERS. Funk, Robert E. // Angiology;Dec1953, Vol. 4 Issue 6, p480
Discusses the use of Hydergine drug in the treatment of circulatory disorders. Safety profile of the drug; Adverse effects; Toxicity of Hydergine.
- Clusters of metabolic risk factors predict cardiovascular events in hypertension with target-organ damage: the LIFE study. de Simone, G.; Olsen, M. H.; Wachtell, K.; Hille, D. A.; Dahlöf, B.; Ibsen, H.; Kjeldsen, S. E.; Lyle, P. A.; Devereux, R. B. // Journal of Human Hypertension;Aug2007, Vol. 21 Issue 8, p625
The relation of metabolic syndrome (MetS) with cardiovascular outcome may be less evident when preclinical cardiovascular disease is present. We explored, in a post hoc analysis, whether MetS predicts cardiovascular events in hypertensive patients with electrocardiographic left ventricular...
- GenSalt: rationale, design, methods and baseline characteristics of study participants. // Journal of Human Hypertension;Aug2007, Vol. 21 Issue 8, p639
Hypertension is a complex disorder influenced by genetic and environmental determinants and their interactions. The objectives of the Genetic Epidemiology Network of Salt Sensitivity (GenSalt) are to localize and identify genes related to blood pressure (BP) responses to dietary sodium and...